Point-of-care devices market seen reaching $48.88 billion by 2030

The point-of-care devices market is projected to grow from $31.46 billion in 2025 to $48.88 billion by 2030, driven by demand for faster diagnostics, home care, and decentralized testing. North America led the market in 2025, while Asia-Pacific is expected to grow the fastest.

Why it matters: - Point-of-care devices are becoming central to faster diagnosis and treatment because they deliver test results near the patient instead of sending samples to centralized labs. - The market’s growth reflects broader pressure on health systems to make testing more accessible in hospitals, clinics, emergency care and homes. - Diagnostic imaging demand is also reinforcing adoption as chronic disease rates rise and earlier clinical decisions become more important.

What happened: - The point-of-care devices market is projected to rise from $31.46 billion in 2025 to $34.44 billion in 2026. - The 2025-2026 increase implies a 9.5% compound annual growth rate. - The market is forecast to reach $48.88 billion by 2030. - Growth from 2026 to 2030 is expected to continue at a 9.1% CAGR. - North America held the largest share of the market in 2025. - Asia-Pacific is expected to be the fastest-growing region during the forecast period.

The details: - Point-of-care devices are medical diagnostic tools used at or near the patient’s location, including hospitals, clinics and homes. - These devices are designed to provide quick test results and support timely clinical decisions. - Key growth drivers include limited access to centralized labs, the rising prevalence of chronic illnesses, the need for rapid clinical decisions, expanding primary healthcare services and stronger demand for bedside diagnostics. - Longer-term growth is being shaped by microfluidic and biosensor innovations, wider use of wearable and remote monitoring tools, growth in home healthcare, increased infectious-disease surveillance and integration with digital health platforms. - Market trends include more on-site rapid diagnostic testing, growing use of home-based and self-testing kits, device miniaturization, a shift toward decentralized care and rising use in emergency and critical care settings. - Diagnostic imaging is a major growth driver because it supports visual analysis of the body for medical assessment and intervention. - Point-of-care devices help diagnostic imaging by offering portable, compact systems suitable for clinics, bedside use and remote care. - The devices can reduce turnaround times by delivering faster imaging results and improving clinical decisions. - The UK National Health Service reported 47.2 million imaging tests in England for the year ending March 2024, up 4.8% from 45.0 million a year earlier. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - The 2026 report package adds market attractiveness scoring, total addressable market analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, key technology analysis and updated graphics and tables. - More information is available in the full report. - A free sample is available through the sample report.

Between the lines: - The forecast suggests point-of-care testing is moving from a convenience feature to a core part of care delivery. - The strongest tailwinds are coming from decentralized care models, which favor faster decision-making and fewer dependencies on centralized laboratory infrastructure. - The expansion of home healthcare and self-testing indicates more testing is moving outside traditional clinical settings.

What's next: - The market’s next phase will likely be shaped by broader adoption of portable diagnostics, remote monitoring and connected health platforms. - Growth in infectious-disease surveillance and emergency care use cases could widen the market beyond routine testing. - Asia-Pacific’s expected growth leadership may shift more commercial attention and investment toward the region.

The bottom line: - Point-of-care devices are set for sustained double-digit-style expansion through 2030, powered by demand for faster, more decentralized and more accessible diagnostics.